| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMSA0708739 |
| P698 | PubMed publication ID | 18579814 |
| P50 | author | Douglas F. Easton | Q59812154 |
| Paul D P Pharoah | Q61822938 | ||
| Antonis C Antoniou | Q89766295 | ||
| P2093 | author name string | Bruce A J Ponder | |
| P2860 | cites work | Why most published research findings are false | Q21092395 |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| prevention | Q1717246 | ||
| P304 | page(s) | 2796-2803 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Polygenes, risk prediction, and targeted prevention of breast cancer | |
| P478 | volume | 358 |
| Q39167311 | "It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer |
| Q39990313 | 'Over-the-counter' genetic testing: what does it really mean for primary care? |
| Q94476316 | A Collective Ranking Method for Genome-wide Association Studies |
| Q47600111 | A better coefficient of determination for genetic profile analysis |
| Q33915049 | A compendium of genome-wide associations for cancer: critical synopsis and reappraisal |
| Q92066484 | A flexible and parallelizable approach to genome-wide polygenic risk scores |
| Q37517719 | A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence |
| Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
| Q37566380 | A multiclass likelihood ratio approach for genetic risk prediction allowing for phenotypic heterogeneity |
| Q35108072 | A multistage association study identifies a breast cancer genetic locus at NCOA7. |
| Q34085748 | A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). |
| Q35626744 | A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer |
| Q37589578 | A scoring strategy combining statistics and functional genomics supports a possible role for common polygenic variation in autism |
| Q36250581 | A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population |
| Q35132031 | A stratified genetic risk assessment for testicular cancer |
| Q34043155 | A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis |
| Q33883502 | Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q35592936 | Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK. |
| Q35951346 | Advances in breast cancer: pathways to personalized medicine |
| Q33767039 | An alternative model for (breast) cancer predisposition |
| Q34344701 | An epidemiological perspective on the future of direct-to-consumer personal genome testing |
| Q26864696 | Applying what we know to accelerate cancer prevention |
| Q34765941 | Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q34267477 | Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information |
| Q38613552 | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
| Q64056497 | Association analyses identify 31 new risk loci for colorectal cancer susceptibility |
| Q35111413 | Association between mitogen-activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis of 20 case-control studies |
| Q37368046 | Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis |
| Q35058926 | Association of cellular and molecular responses in the rat mammary gland to 17β-estradiol with susceptibility to mammary cancer |
| Q46762978 | Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. |
| Q52576610 | Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. |
| Q37375847 | Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence |
| Q33725581 | Being more realistic about the public health impact of genomic medicine |
| Q33679037 | Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer |
| Q58047301 | Beyond odds ratios — communicating disease risk based on genetic profiles |
| Q37594329 | Brain plasticity and genetic factors |
| Q42363834 | Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q34873841 | Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec |
| Q24602679 | Breast cancer in the personal genomics era |
| Q33892384 | Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population |
| Q36393157 | Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women |
| Q36393193 | Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement |
| Q37410693 | Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab |
| Q37081117 | Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation |
| Q43054148 | Breast cancer susceptibility variants alter risk in familial ovarian cancer |
| Q34161642 | Breast cancer susceptibility: current knowledge and implications for genetic counselling |
| Q36857180 | Breed-predispositions to cancer in pedigree dogs. |
| Q35073667 | Bridge: a GUI package for genetic risk prediction |
| Q37137088 | Cancer genetic association studies in the genome-wide age. |
| Q85070412 | Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint |
| Q38996690 | Clinical implications of genomics for cancer risk genetics |
| Q37350182 | Clinical implications of low-penetrance breast cancer susceptibility alleles |
| Q42791664 | Comment on "the predictive capacity of personal genome sequencing". |
| Q35868793 | Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34493797 | Common low-penetrance risk variants associated with breast cancer in Polish women |
| Q36141922 | Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia |
| Q36387040 | Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy |
| Q35570099 | Comparing the value of mammographic features and genetic variants in breast cancer risk prediction |
| Q90250007 | Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study |
| Q37235167 | Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. |
| Q33780848 | Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history |
| Q63433280 | Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction |
| Q31064480 | Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk |
| Q35983958 | Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing |
| Q37409157 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals |
| Q37890286 | Current status of genome-wide association studies in cancer |
| Q37395410 | Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. |
| Q41651668 | Development of risk scoring system for stratifying population for hepatocellular carcinoma screening. |
| Q89161935 | Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score |
| Q38667840 | Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study |
| Q33623531 | Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression |
| Q37360234 | Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer |
| Q24810389 | ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer |
| Q34670325 | Emerging Concepts in Breast Cancer Risk Prediction |
| Q42869013 | Empirical evaluation of gene and environment interactions: methods and potential |
| Q30854346 | Estimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer |
| Q54432937 | Estrogen receptor alpha polymorphisms and the risk of malignancies. |
| Q56780467 | Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? |
| Q37691100 | Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway. |
| Q38845261 | Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk |
| Q38739215 | Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk. |
| Q34551122 | FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors |
| Q43758408 | Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families |
| Q55451895 | Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases. |
| Q22122198 | Finding the missing heritability of complex diseases |
| Q81715644 | From risk to function |
| Q36408445 | Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant |
| Q64251583 | Genetic Epidemiology of Breast Cancer in Latin America |
| Q33965090 | Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women |
| Q36053127 | Genetic architecture of colorectal cancer |
| Q39579388 | Genetic prediction of quantitative lipid traits: comparing shrinkage models to gene scores |
| Q44310648 | Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer |
| Q37156413 | Genetic susceptibility loci for breast cancer by estrogen receptor status |
| Q41130542 | Genetic susceptibility to breast cancer |
| Q33837394 | Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk |
| Q22330767 | Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders |
| Q47207156 | Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry |
| Q35557640 | Genetic variants in the MRPS30 region and postmenopausal breast cancer risk |
| Q28486256 | Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa |
| Q37149270 | Genome-based prediction of common diseases: methodological considerations for future research |
| Q56375615 | Genome-wide association analysis identifies a meningioma risk locus at 11p15.5 |
| Q37637724 | Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia |
| Q22064616 | Genome-wide association studies and the clinic: a focus on breast cancer |
| Q34193988 | Genome-wide association studies of cancer |
| Q34241300 | Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity |
| Q36145972 | Genome-wide association study identifies multiple susceptibility loci for glioma |
| Q52720511 | Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. |
| Q38873936 | Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors |
| Q37156098 | Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci |
| Q57910661 | Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations |
| Q90950429 | Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
| Q34473904 | Genomic prediction of complex human traits: relatedness, trait architecture and predictive meta-models |
| Q85246836 | Genomic risk prediction |
| Q42353857 | Genomics and breast cancer: the different levels of inherited susceptibility. |
| Q33591622 | Germline mutation in the RAD51B gene confers predisposition to breast cancer |
| Q33606675 | Germline mutations and polymorphisms in the origins of cancers in women |
| Q91525724 | Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico |
| Q33356511 | Hereditary breast cancer: ever more pieces to the polygenic puzzle |
| Q27024251 | Heritability in the genome-wide association era |
| Q36778955 | High-Dimensional Structured Feature Screening Using Binary Markov Random Fields |
| Q33370698 | How does age affect baseline screening mammography performance measures? A decision model |
| Q41978253 | Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations |
| Q34096129 | Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes? |
| Q34743854 | Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm |
| Q37357916 | Identification of discriminating biomarkers for human disease using integrative network biology |
| Q91451448 | Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk |
| Q37039765 | Identification of personal risk of breast cancer: genetics |
| Q33585860 | Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk |
| Q26825771 | Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues |
| Q91989559 | Improving breast cancer risk prediction by using demographic risk factors, abnormality features on mammograms and genetic variants |
| Q34225990 | Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer |
| Q36017113 | Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases |
| Q37614763 | Incorporating genomics into breast and prostate cancer screening: assessing the implications |
| Q89955829 | Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects |
| Q37304142 | Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research |
| Q36924790 | Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors. |
| Q37861028 | Inherited mutations in breast cancer genes--risk and response |
| Q82750617 | Integration of polymorphic data into the clinical management of breast cancer |
| Q37388847 | Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci |
| Q37306204 | Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunities |
| Q39094483 | Is mammography screening history a predictor of future breast cancer risk? |
| Q59379536 | Is the time right for translation research in genomics? |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q35075176 | Lactogens and estrogens in breast cancer chemoresistance |
| Q42343135 | Life insurance: genomic stratification and risk classification |
| Q34494290 | Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation |
| Q54294921 | Low penetrance alleles as risk modifiers in familial and sporadic breast cancer. |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q91678289 | Making Genetic Testing More Clinically Valuable |
| Q36998162 | Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry |
| Q36508076 | Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5. |
| Q55257859 | Medical Myths and Legends: Presidential Address to the Ulster Medical Society. 6th October 2016. |
| Q43293575 | Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers |
| Q37340699 | Missing heritability of complex diseases: Enlightenment by genetic variants from intermediate phenotypes |
| Q36133352 | Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores |
| Q37722954 | Molecular epidemiology and its current clinical use in cancer management |
| Q37181547 | Molecular genetics of breast and ovarian cancer: recent advances and clinical implications |
| Q33759709 | Mutagen sensitivity, tobacco smoking and breast cancer risk: a case-control study |
| Q37162103 | Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype |
| Q27004471 | Ovarian cancer screening--current status, future directions |
| Q35546414 | Participation in genetic testing research varies by social group |
| Q55110010 | Pathology of hereditary breast cancer. |
| Q41376969 | Paying for personalized care: cancer biomarkers and comparative effectiveness |
| Q34064069 | Performance of common genetic variants in breast-cancer risk models |
| Q84177042 | Personal genomic testing as part of the complete breast cancer risk assessment: a case report |
| Q34815108 | Personalized estimates of breast cancer risk in clinical practice and public health |
| Q46814959 | Personalized genomic information: preparing for the future of genetic medicine |
| Q36641610 | Personalized medicine in screening for malignant disease: a review of methods and applications |
| Q37333975 | Personalized screening for cancers: should we consider polygenic profiling? |
| Q34938911 | Personalizing health care: feasibility and future implications |
| Q55122850 | Personalizing healthcare: from genetics through payment to improving care? |
| Q33896815 | Pitfalls of predicting complex traits from SNPs |
| Q37474410 | Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes |
| Q37541989 | Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes |
| Q64461064 | Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood |
| Q98611548 | Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions |
| Q47561710 | Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts |
| Q58553352 | Polygenic risk scoring and prediction of mental health outcomes |
| Q37062641 | Polygenic susceptibility to breast cancer: current state-of-the-art |
| Q34977428 | Polygenic susceptibility to prostate and breast cancer: implications for personalised screening |
| Q47554600 | Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning |
| Q36233914 | Population-based screening in the era of genomics |
| Q36599573 | Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial |
| Q28943457 | Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility |
| Q36097440 | Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers |
| Q34337027 | Power and predictive accuracy of polygenic risk scores. |
| Q37733169 | Predicting the future of genetic risk prediction |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
| Q57471049 | Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data |
| Q47409320 | Predictive accuracy of combined genetic and environmental risk scores |
| Q45771188 | Predictive factors of brain metastasis in patients with breast cancer |
| Q36079558 | Prevention of eating disorders: A systematic review of randomized, controlled trials. |
| Q37059182 | Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies |
| Q43102971 | Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population |
| Q39852672 | Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers? |
| Q34454426 | Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation |
| Q34811135 | Public health genomics and personalized prevention: lessons from the COGS project |
| Q33855679 | Quantifying the underestimation of relative risks from genome-wide association studies |
| Q49662743 | Rat Models of 17beta-Estradiol-Induced Mammary Cancer Reveal Novel Insights into Breast Cancer Etiology and Prevention. |
| Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
| Q36295073 | Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. |
| Q40955207 | Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population |
| Q36245573 | Reproductive aging-associated common genetic variants and the risk of breast cancer |
| Q39326953 | Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci |
| Q26991921 | Risk determination and prevention of breast cancer |
| Q37376106 | Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background |
| Q36545643 | Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population |
| Q35136955 | Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening |
| Q37453871 | Role of genetic polymorphisms and ovarian cancer susceptibility |
| Q36322904 | SNPs and breast cancer risk prediction for African American and Hispanic women |
| Q35990450 | Summarizing polygenic risks for complex diseases in a clinical whole-genome report |
| Q26852061 | Surgery in the era of the 'omics revolution |
| Q38058727 | Systems genetics in "-omics" era: current and future development |
| Q83449905 | Testing challenges: evaluation of novel diagnostics and molecular biomarkers |
| Q34858803 | The 6q22.33 locus and breast cancer susceptibility |
| Q37785219 | The Application of Genetics and Genomics to Cancer Prevention |
| Q33729461 | The German National Cohort: aims, study design and organization |
| Q89622398 | The Menstrual Cycle and Risk of Breast Cancer: A Review |
| Q53295921 | The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk |
| Q36742590 | The benefits of using genetic information to design prevention trials |
| Q35547325 | The contribution of genetic variants to disease depends on the ruler |
| Q36925187 | The genetics of breast cancer: risk factors for disease |
| Q42287456 | The impact of genomics on public health practice: the case for change |
| Q34775177 | The inherited genetics of ovarian and endometrial cancer |
| Q28278125 | The molecular pathology of cancer |
| Q45671065 | The polymorphism of EGFR 142285G > A exerts no risk effect on breast cancer |
| Q34105177 | The pursuit of genome-wide association studies: where are we now? |
| Q36931512 | The role of chronic inflammation in obesity-associated cancers |
| Q34458456 | The role of genome sequencing in personalized breast cancer prevention |
| Q33911709 | The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer |
| Q37397442 | The utility of comparative genetics to inform breast cancer prevention strategies |
| Q28385221 | Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation |
| Q38811931 | Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease |
| Q33988308 | Transforming growth factor β signaling pathway associated gene polymorphisms may explain lower breast cancer risk in western Indian women |
| Q42697902 | Translating genomics into improved population screening: hype or hope? |
| Q28397316 | Using DNA fingerprints to infer familial relationships within NHANES III households |
| Q28392540 | Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty |
| Q37842125 | Utility of genetic determinants of lipids and cardiovascular events in assessing risk |
| Q57040851 | Validation of a genetic risk score for Arkansas women of color |
| Q93058508 | Variable prediction accuracy of polygenic scores within an ancestry group |
| Q27007571 | We screen newborns, don't we?: realizing the promise of public health genomics |
| Q37612075 | What have the genomics ever done for the psychoses? |
| Q89547730 | iCARE: An R package to build, validate and apply absolute risk models |
Search more.